Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
Luis G Paz-Ares, Stéphane Champiat, Wei-Chu Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael Joseph Boyer and 19 more
- Rank
- 14 of 529
- Percentile
- top 2.7%
- Where
- Journal of Clinical Oncology, 2023
- Citations
- 342
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.